Secondary Cardiovascular Disease Prevention With Semaglutide at Cash Price Is Cost-Effective

Further cost reductions needed to increase the value of the therapy for the health care system
glp1 semaglutide
Adobe Stock
Medically Reviewed By:
Farrokh Sohrabi, M.D.
Published on: 
Updated on: 
Loading content, please wait...